We are live on ! Find out more
KCM

KRS Capital Management Portfolio holdings

AUM $215M
1-Year Est. Return 69.3%
This Fund
S&P 500
This Quarter Est. Return
+23.08%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$16.5M
Cap. Flow
-$1.03M
Cap. Flow %
-0.83%
Top 10 Hldgs %
48.52%
Holding
122
New
8
Increased
43
Reduced
55
Closed
4

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$428K
2
SNOW icon
Snowflake
SNOW
+$327K
3
DELL icon
Dell
DELL
+$244K
4
AMGN icon
Amgen
AMGN
+$235K
5
ZS icon
Zscaler
ZS
+$219K

Top Sells

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$748K
2
NVDA icon
NVIDIA
NVDA
+$603K
3
BLK icon
Blackrock
BLK
+$241K
4
ABNB icon
Airbnb
ABNB
+$216K
5
PG icon
Procter & Gamble
PG
+$189K

Sector Composition

Rank Sector Weight
1 Technology 56.53%
2 Healthcare 12.44%
3 Financials 6.81%
4 Consumer Discretionary 6.22%
5 Industrials 5.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EW icon
101
Edwards Lifesciences
EW
$51.7B
$261K 0.21%
2,735
-365
-12% -$30.7K
EA
102
DELISTED
Electronic Arts
EA
$249K 0.2%
1,880
+275
+17% +$37.7K
XBI icon
103
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$241K 0.19%
2,538
+25
+1% +$2.32K
CG icon
104
Carlyle Group
CG
$17.4B
$240K 0.19%
5,120
-1,660
-24% -$71.8K
ICE icon
105
Intercontinental Exchange
ICE
$84.6B
$238K 0.19%
1,730
– –
PYPL icon
106
PayPal
PYPL
$50.4B
$238K 0.19%
3,546
-506
-12% -$31.1K
EXPE icon
107
Expedia Group
EXPE
$37.3B
$237K 0.19%
1,723
+325
+23% +$46.2K
GS icon
108
Goldman Sachs
GS
$303B
$228K 0.18%
547
– –
U icon
109
Unity
U
$18.8B
$225K 0.18%
8,445
-2,170
-20% -$68.2K
NVO
110
Novo Nordisk
NVO
$209B
$224K 0.18%
+1,745
New +$208K
TER icon
111
Teradyne
TER
$58.8B
$223K 0.18%
+1,976
New +$206K
KO icon
112
Coca-Cola
KO
$375B
$222K 0.18%
3,632
-1,013
-22% -$60.9K
ADP icon
113
Automatic Data Processing
ADP
$108B
$221K 0.18%
+885
New +$216K
EXAS
114
DELISTED
Exact Sciences
EXAS
$213K 0.17%
3,090
-650
-17% -$41.1K
PNC icon
115
PNC Financial Services
PNC
$101B
$203K 0.16%
+1,253
New +$189K
CVS icon
116
CVS Health
CVS
$122B
$202K 0.16%
2,530
-434
-15% -$33.2K
OC icon
117
Owens Corning
OC
$12.4B
$200K 0.16%
+1,200
New +$183K
SOFI icon
118
SoFi Technologies
SOFI
$23.5B
$83.4K 0.07%
+11,420
New +$90.7K
ABNB icon
119
Airbnb
ABNB
$105B
– –
-1,586
Closed -$216K
BLK icon
120
Blackrock
BLK
$177B
– –
-296
Closed -$241K
F icon
121
Ford
F
$56B
– –
-10,077
Closed -$123K
KRTX
122
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-2,364
Closed -$748K
1 2 3 4
5

Similar funds

VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM
CMBA
C.M. Bidwell & Associates Honolulu, Hawaii $214M AUM 18.82% 1-Year Est. Return
IH
IES Holdings Houston, Texas $214M AUM

KRS Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, KRS Capital Management held 122 positions worth $124M, up 15% from $107M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

KRS Capital Management's Q1 2024 filing shows 8 new, 43 increased, 55 reduced and 4 closed positions. Its largest new stake was RTX Corp: 4,739 shares worth $462K. The largest sale was Karuna Therapeutics, Inc. Common Stock, an estimated $748K.

By sector, the portfolio is most concentrated in Technology at 57% of assets, up from 52% a quarter earlier, followed by Healthcare and Financials.

  • KRS Capital Management's largest Q1 2024 buy was RTX Corp: 4,739 shares worth $462K.
  • KRS Capital Management added most to Snowflake in Q1 2024, an estimated $327K increase.
  • KRS Capital Management's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $603K.
  • KRS Capital Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $748K.
  • KRS Capital Management's ten largest holdings make up 49% of its $124M portfolio in Q1 2024.
  • KRS Capital Management opened 8 new positions and closed 4 in Q1 2024.
  • KRS Capital Management's portfolio value rose 15% quarter-over-quarter to $124M.

Based on KRS Capital Management's 13F filing for Q1 2024, filed 16 Apr 2024.